ArticleCancer cell international2023

Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials.

Ibrahim Elmakaty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.